Synthesis and chemical properties of adamantylated nucleic bases and related compounds

Pharmaceutical Chemistry Journal

Volumn 47, Issue 5, 2013, Pages 264-280

  Shokova, E A ^a   Kovalev, V V ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

adamantane derivatives; nucleic bases

Indexed keywords

ADAMANTANE DERIVATIVE; ADAMANTYLATED NUCLEIC BASE; HETEROCYCLIC COMPOUND; NUCLEIC ACID BASE; UNCLASSIFIED DRUG;

ARTICLE; PHYSICAL CHEMISTRY; SYNTHESIS;

EID: 84887488948     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-013-0942-1     Document Type: Article

References (57)

1. M.-G. A. Shvekhgeimer, Usp. Khim., 65(7), 603-647 (1996).
2. V. P. Litvinov and M.-G. A. Shvekhgeimer, Zh. Org. Khim., 33(10), 1447-1471 (1997).
3. M.-G. A. Shvekhgeimer and V. P. Litvinov, Zh. Org. Khim., 35(2), 183-220 (1999).
4. M.-G. A. Shvekhgeimer, Khim. Geterotsikl. Soedin., No. 4, 435-482 (1997).
5. V. P. Litvinov, Khim. Geterotsikl. Soedin., No. 1, 12-39 (2002).
6. J. Balzarini, B. Orzeszko-Krzesinska, J. K. Maurin, and A. Orzeszko, Eur. J. Med. Chem., 44(1), 303-311 (2009).
7. B. Orzeszko, M. Fedorynski, A. E. Laudy, et al., Acta Pol. Pharm., 63(5), 374-377 (2006).
8. J. Gao, R. F. Henry, T. G. Pagano, et al., Tetrahedron Lett., 48(41), 7395-7398 (2007).
9. N. V. Makarova, M. N. Zemtsova, and I. K. Moiseev, Khim. Geterotsikl. Soedin., No. 7, 912-915 (2001).
10. N. V. Makarova, M. N. Zemtsova, and I. K. Moiseev, Khim. Geterotsikl. Soedin., No. 5, 709-711 (2003).
11. N. V. Makarova, E. I. Boreko, I. K. Moiseev, et al., Khim-farm. Zh., 36(1), 5-7 (2002).
12. I. A. Novakov, B. S. Orlinson, and M. B. Navrotskii, Zh. Org. Khim., 45(2), 325-326 (2009).
13. N. Kolocouris, G. Zoidis, G. B. Foscolos, et al., Bioorg. Med. Chem. Lett., 17(15), 4358-4362 (2007).
14. B. Orzeszko, A. E. Laudy, B. J. Starosciak, et al., Acta Pol. Pharm. Drug Res., 61(6), 455-460 (2004).
15. B. Orzeszko, Z. Kazimierczuk, J. K. Maurin, et al., Il Farmaco, 59(12), 929-937 (2004).
16. V. Kovalev, E. Shokova, A. Shmailov, et al., Eur. J. Org. Chem., 19, 3754-3761 (2010).
17. E. A. Shokova and V. V. Kovalev, Usp. Khim., 80(10), 971-995 (2011).
18. V. V. Kovalev, E. A. Shokova, and A. K. Rozov, RU Pat. No. 2,064,930 (1996); Byull. Izobret., No. 96 (1996).
19. V. V. Kovalev, A. N. Khomich, E. A. Shokova, and Yu. N. Luzikov, New J. Chem., 20(4), 483-492 (1996).
20. E. A. Shokova, A. E. Motornaya, A. K. Shestakova, and V. V. Kovalev, Tetrahedron Lett., 45(4), 6465-6469 (2004).
21. E. Erochina, E. Shokova, Yu. Luzikov, and V. Kovalev, Synthesis, 7, 851-854 (1995).
22. V. V. Kovalev, O. A. Fedorova, and E. A. Shokova, Zh. Org. Khim, 23(9), 1882-1886 (1987).
23. E. Shokova, V. Tafeenko, and V. Kovalev, Tetrahedron Lett., 43(29), 5153-5156 (2002).
24. E. A. Shokova, E. V. Khomich, N. N. Akhmetov, et al., Zh. Org. Khim., 39(3), 400-414 (2003).
25. E. A. Shokova, L. M. Alimbarova, and V. V. Kovalev, Khim.-farm. Zh., 33(7), 30-33 (1999).
26. V. V. Kovalev, E. A. Shokova, and A. K. Rozov, Tetrahedron, 52(11), 3983-3990 (1996).
27. E. Shokova, T. Mousoulou, Yu. Luzikov, and V. Kovalev, Synthesis, 9, 1034-1040 (1997).
28. E. A. Shokova, T. Mousoulou, Yu. N. Luzikov, and V. V. Kovalev, Zh. Org. Khim., 35(6), 869-881 (1999).
29. Z. Kazimierczuk and A. Orzeszko, Helv. Chim. Acta., 82(11), 2020-2027 (1999).
30. J. K. Maurin, W. Lasek, A. Gorska, et al., Chem. Biodiversity, 1(10), 1498-1512 (2004).
31. J. K. Maurin, W. Lasek, A. Gorska, et al., Anti-Cancer Drug Des., 16(2), 73-80 (2001).
32. A. Shmailov, L. Alimbarova, E. Shokova, et al., Tetrahedron, 66(16), 3058-3064 (2010).
33. S. Prachayasittikul, A. Worachartcheewan, C. Nantasenamat, et al., Eur. J. Med. Chem., 46(2), 738-742 (2011).
34. S. Prachayasittikul, N. Sornsongkhram, R. Pingaew, et al., Eur. J. Sci. Res., 36(2), 236-245 (2009).
35. B. Orzeszko, T. Switaj, A. B. Jakubowska-Mucka, et al., Z. Naturforsch. B: Chem. Sci., 60(4), 471-475 (2005).
36. A. I. Rakhimov and E. S. Titova, Zh. Org. Khim., 43(10), 92-98 (2007).
37. D. Pappo, S. Shimony, and Y. Kashman, J. Org. Chem., 70(1), 199-205 (2005).
38. D. C. Martyn, A. Nijjar, C. A. Celatka, et al., Bioorg. Med. Chem. Lett., 20(1), 228-231 (2010).
39. A. P. Thomas and T. Nowak, PCT Int. Appl. WO 2006106307 (2006).
40. I. A. Novakov, B. S. Orlinson, R. V. Brunilin, et al., Khim. Geterotsikl. Soedin., 37(10), 1541-1544 (2006).
41. I. A. Novakov, B. S. Orlinson, and M. B. Navrotskii, RU Pat. No. 2,238,269; Byull. Izobret., No. 29 (2004).
42. A. Drabczynska, O. Yuzlenko, M. Kose, et al., Eur. J. Med. Chem., 46(9), 3590-3607 (2011).
43. J. I. Bardagi and R. A. Rossi, J. Org. Chem., 75(15), 5271-5277 (2010).
44. M. Rouchal, M. Necas, and R. Vicha, Acta Crystallogr. Sect. E: Struct. Rep. Online, 65, 1268 (2009).
45. G. Pastorin, C. Bolcato, B. Cacciari, et al., Il Farmaco, 60(4), 299-306 (2005).
46. G. Pastorin, C. Bolcato, B. Cacciari, et al., Il Farmaco, 60(8), 643-651 (2005).
47. K. Petersson, B. T. Pedersen, D. Staerk, et al., Eur. J. Pharm. Sci., 23, 337-345 (2004).
48. K. L. Dueholm, M. Egholm, C. Behrens, et al., J. Org. Chem., 59(19), 5767-5773 (1994).
49. A. Maciollek, M. Munteanu, and H. Ritter, Macromol. Chem. Rev., 211(2), 245-249 (2010).
50. A. Gyrska, M. Andrzejewska, J. Kaminski, and Z. Kazimierczuk, Nucleosides, Nucleotides Nucleic Acids, 22(1), 13-19 (2003).
51. M. V. Skorobogatyi, A. V. Ustinov, I. A. Stepanova, et al., Org. Biomol. Chem., 4(6), 1091-1096 (2006).
52. X.-H. Yang, S. Singh, J. Diakur, and L. I. Wiebe, J. Pharm. Pharm. Sci., 11(2), 32s-43s (2008).
53. P. G. Baraldi, F. Fruttarolo, M. A. Tabrizi, et al., J. Med. Chem., 47(22), 5535-5540 (2004).
54. D. K. Tosh, M. Chinn, L. S. Yoo, et al., Bioorg. Med. Chem., 18(2), 508-517 (2010).
55. R. Chinchilla and C. Najera, Chem. Rev., 107(3), 874-922 (2007).
56. T. E. Tyobeka, R. A. Hancock, and H. Weigel, Tetrahedron, 44(7), 1971-1978 (1988).
57. S. F. Zakrzewski and E. A. Evans, J. Labelled Compd. Radiopharm., 18(5), 683-693 (1981).